Department News

Severe MS: UB Researchers Report Findings on Patients With Rare Form of Disease
10/23/24
A University at Buffalo research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
UB, Medical Community Mourn Loss of Hopkins
10/7/24
The SUNY Distinguished Professor and world-renowned neurosurgeon best known for changing the way stroke patients are treated died Oct. 5.
Levy Awarded Dacey Medal for Cerebrovascular Research
8/19/24
Elad I. Levy, MD, MBA, has been awarded the Ralph G. Dacey Jr. Medal for Outstanding Cerebrovascular Research.
5 Faculty Members Join 4 Medical School Departments
6/28/24
Five faculty members with a variety of clinical and research experience — representing four departments — have joined the Jacobs School of Medicine and Biomedical Sciences during the past few months.
Outstanding Medical School Faculty, Staff Honored in 2024
6/6/24
The Jacobs School of Medicine and Biomedical Sciences celebrated scientific achievements and outstanding service and teaching contributions during its 2024 Faculty and Staff Recognition Awards event.
Creating Tool Set for Oxygen Metabolism Mapping
5/14/24
The new technology could expand access to medical imaging and improve treatment for MS, Alzheimer’s and other neurological disorders.
UB Startup Gets $2.9 Million From NIH to Develop Blood Test for Brain Aneurysms
1/12/24
The funding, awarded to Neurovascular Diagnostics, comes from the National Institutes of Health.
Specialty Fair Opens Eyes to Possible Future Paths
9/28/23
The Jacobs School of Medicine and Biomedical Sciences hosted a networking event Sept. 20 for all medical students.
13 Faculty Members Join 11 Medical School Departments
3/28/23
Thirteen faculty members with a variety of clinical and research experience — representing 11 medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
Study Focuses on Brain Lesions, MS Progression
2/24/23
Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led by the University at Buffalo strongly suggests that the volume of white matter lesions is neither proportional to, nor indicative of, the degree of severe disability in patients.